Mucinex D Tablet, Extended Release
Product Images NDC 63824-057

2 FDA label images from Reckitt Benckiser Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mucinex D (NDC 63824-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reckitt Benckiser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (63824 057 Updated Label 1)

Label (63824 057 Updated Label 1)
Packaging label for Mucinex D Extended-Release Tablets, containing Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg per tablet. The label highlights nasal and chest congestion relief, shows a bi-layer tablet graphic indicating immediate and extended release lasting 12 hours, and states the package contains 18 tablets. Labeler is Reckitt Benckiser LLC.*
FDA Label Image

Back Label (63824 057 Updated Label 2)

Back Label (63824 057 Updated Label 2)
Drug Facts for Mucinex D extended-release tablets with active ingredients guaifenesin 600 mg and pseudoephedrine HCl 60 mg, used to relieve nasal and chest congestion. The panel details uses, warnings, directions, other information, inactive ingredients, and contact information for questions. The label emphasizes dosage instructions, precautions, and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.